U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 3,981 records

Showing results for "cardiovascular".
Users also searched for: statin

  1. Pseudo-obstruction But a Real Perforation | PSNet

    psnet.ahrq.gov/web-mm/pseudo-obstruction-real-perforation
    April 01, 2015 - While neostigmine is effective, the risk of cardiovascular collapse limits its use. … Overall, the risk of serious complications from colonoscopy (which includes cardiovascular events, severe

  2. Transitions in Adolescent Medicine | PSNet

    psnet.ahrq.gov/web-mm/transitions-adolescent-medicine
    August 04, 2021 - E, Uzark K, et al; American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular … Disease in the Young, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Council

  3. Section4 (pdf file)

    hcup-us.ahrq.gov/reports/factsandfigures/2008/pdfs/section4.pdf
    January 01, 2008 -  Five of the twenty most expensive conditions were cardiovascular: coronary atherosclerosis, acute …  With the exception of costs of stays for cardiac dysrhythmias, the costs for these cardiovascular

  4. Promoting Self-Management in Stroke Survivors Using Health-IT - Final Report (pdf file)

    digital.ahrq.gov/sites/default/files/docs/publication/r21hs021794-lakshiminarayan-final-report-2015.pdf
    January 01, 2015 - systems, in populations including both stroke survivors as well as those at high risk of stroke and cardiovascular … Current science on consumer use of mobile health for cardiovascular disease prevention: A scientific

  5. Introduction-User-Guide-To-Ocer 130129 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/introduction-user-guide-to-ocer_130129.pdf
    April 26, 2012 - ADHD drugs and serious cardiovascular events in children and young adults. … ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.

  6. Section 5: Evidence, Attachment 1: AAP Guideline Evidence (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
    January 01, 2009 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.

  7. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49733/psn-pdf
    May 01, 2015 - E, Uzark K, et al; American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular … Disease in the Young, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Council

  8. Chapter 4. Evaluation Design (continued) | Agency for Healthcare Research and Quality

    www.ahrq.gov/research/findings/final-reports/diabetesnetwork/diabnet4a.html
    October 01, 2014 - the Mid-Atlantic Primary Care Association develop its quality improvement strategy for diabetes and cardiovascular … with the Mid-Atlantic Primary Care Association on its quality improvement initiative on diabetes and cardiovascular

  9. Self-Measured Blood Pressure: Future Research Needs (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/measuring-blood-pressure-future_research.pdf
    August 01, 2012 - The benefits of long- term BP control are presumed to include a reduction in clinical cardiovascular … How do different metrics of aggregated SMBP readings predict risk for cardiovascular disease? … outcome of myocardial infarction, stroke, or death from cardiovascular causes. … factor (i.e., those without a history of cardiovascular disease) it was lower at 10 percent. … disease or diabetes would be expected to have lower risk of cardiovascular disease.

  10. Maskedstats Nrd 2022 Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2022_Core_Weighted.PDF
    January 01, 2022 - CVASC PROC WITH DRUG-ELUTING STENT WITH MCC OR 4+ ARTERIES OR STENTS 100,906 0.31% 246: PERCUTANEOUS CARDIOVASCULAR … 0.00% 249: PERC CVASC PROC WITH NON-DRUG-ELUTING STENT WITHOUT MCC 1,711 0.01% 249: PERCUTANEOUS CARDIOVASCULAR … 0.01% 251: PERC CVASC PROC WITHOUT CORONARY ARTERY STENT WITHOUT MCC 8,355 0.03% 251: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES WITH MCC 53,929 0.16% 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES WITH CC 43,646 0.13% 272 … : OTHER MAJOR CARDIOVASCULAR PROCEDURES WITHOUT CC/MCC 15,471 0.05% 273: PERCUTANEOUS AND OTHER INTRACARDIAC

  11. Kid 2022 Maskedstats Core (pdf file)

    hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2022_MaskedStats_Core.PDF
    January 01, 2022 - = 10 *.**% 247: PERC CVASC PROC WITH DRUG-ELUTING STENT WITHOUT MCC <= 10 *.**% 247: PERCUTANEOUS CARDIOVASCULAR … PROC WITH NON-DRUG-ELUTING STENT WITH MCC OR 4+ ARTERIES OR STENTS <= 10 *.**% 248: PERCUTANEOUS CARDIOVASCULAR … *.**% 249: PERC CVASC PROC WITH NON-DRUG-ELUTING STENT WITHOUT MCC <= 10 *.**% 249: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES WITH MCC 2,098 0.07% 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES WITH CC 748 0.02% 272: … OTHER MAJOR CARDIOVASCULAR PROCEDURES WITHOUT CC/MCC 319 0.01% 273: PERCUTANEOUS AND OTHER INTRACARDIAC

  12. Kid 2022 Maskedstats Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2022_MaskedStats_Core_Weighted.PDF
    January 01, 2022 - = 50 *.**% 247: PERC CVASC PROC WITH DRUG-ELUTING STENT WITHOUT MCC <= 50 *.**% 247: PERCUTANEOUS CARDIOVASCULAR … PROC WITH NON-DRUG-ELUTING STENT WITH MCC OR 4+ ARTERIES OR STENTS <= 50 *.**% 248: PERCUTANEOUS CARDIOVASCULAR … *.**% 249: PERC CVASC PROC WITH NON-DRUG-ELUTING STENT WITHOUT MCC <= 50 *.**% 249: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES WITH MCC 2,868 0.05% 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES WITH CC 1,018 0.02% 272 … : OTHER MAJOR CARDIOVASCULAR PROCEDURES WITHOUT CC/MCC 434 0.01% 273: PERCUTANEOUS AND OTHER INTRACARDIAC

  13. Evidence Summary: High Body Mass Index in Children and Adolescents: Interventions | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/obesity-in-children-and-adolescents-screening
    June 18, 2024 - life, functioning, depression, medical events or conditions that may be associated with high BMI [eg, cardiovascular … Health outcomes, including quality of life, depression, and cardiovascular-related morbidity or mortality … suggest that high BMI in childhood is associated with an increased risk of premature mortality and cardiovascular … Childhood cardiovascular risk factors and adult cardiovascular events. … What change in body mass index is required to improve cardiovascular outcomes in childhood and adolescent

  14. 2016-05 (pdf file)

    hcup-us.ahrq.gov/reports/methods/2016-05.pdf
    January 01, 2016 - The Advisory Board Company, Cardiovascular Rounds. … April 29, 2011. http://www.advisory.com/Research/Cardiovascular- Roundtable/Cardiovascular-Rounds/2011 … /Regulations-and-Guidance/Guidance/Manuals/Downloads/clm104c04.pdf http://www.advisory.com/Research/Cardiovascular-Roundtable … /Cardiovascular-Rounds/2011/04/The-Expanding-Role-of-Observation-Services-Q-A-with-Brian-Contos http: … //www.advisory.com/Research/Cardiovascular-Roundtable/Cardiovascular-Rounds/2011/04/The-Expanding-Role-of-Observation-Services-Q-A-with-Brian-Contos

  15. Evidence Report on the (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
    November 01, 2010 - Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. … Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular … Cardiovascular outcomes and all- cause mortality: exploring the interaction between CKD and cardiovascular … Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. … Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.

  16. Jan-2017-Cholesterol-Wg-Notes (doc file)

    cds.ahrq.gov/sites/default/files/workgroups/216/jan-2017-cholesterol-wg-notes.docx
    January 01, 2017 - The WG also offered considerations surrounding the provision of medication recommendations based on cardiovascular … The WG also debated the merits of using multiple risk tools for cardiovascular risk, and whether there … for the longitudinal risk assessment tool in their organizations/initiatives: · The Million Hearts® Cardiovascular … . 1 in 10 patients vs. 10% of patients); · Shared decision making must include not just the risk of cardiovascular

  17. Covariate Selection for Observational Comparative Effectiveness Research

    effectivehealthcare.ahrq.gov/sites/default/files/covariate-selection-chapter-7.pptx
    January 01, 2013 - For example, family history of heart disease is a measured variable indicating someone’s risk for cardiovascular … after treatment initiation (C1) is on the causal pathway between antihypertensive treatment (A0) and cardiovascular … pressure measured after the treatment was initiated (C1), because most of the medication’s effects on cardiovascular … For example, if we were interested in comparing cardiovascular events between subjects who were completely

  18. Customizing Value-based Methods to Prioritize Implementation of Pharmacogenomic Clinical Decision Support for Learning Health Systems - Final Report (pdf file)

    digital.ahrq.gov/sites/default/files/docs/citation/r21hs026544-devine-final-report-2022.pdf
    January 01, 2022 - (Aim 2) Key Words PGx-CDs program, economic evaluation, cardiovascular diseases 3 … clopidogrel use for ACS to avert one major non-fatal clinical event, 287 alerts were needed to avert one cardiovascular … program helped to reduce the number of major non-fatal clinical events by 16.32 and the number of cardiovascular … Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular

  19. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)

    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(6).pdf
    November 01, 2014 - Obesity and Cardiovascular Health 3. Behavior and Development 4. Infectious Diseases 5. … Obesity and Cardiovascular Health Infectious Diseases TABLE … (Grade D) Cardiovascular Disease and Cancer: Preventive Medication Carotid Artery Stenosis: … Obesity and Cardiovascular Health 1. … to promote a healthful diet and physical activity for cardiovascular disease prevention.

  20. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)

    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(9).pdf
    November 01, 2014 - Obesity and Cardiovascular Health 3. Behavior and Development 4. Infectious Diseases 5. … Obesity and Cardiovascular Health Infectious Diseases TABLE … (Grade D) Cardiovascular Disease and Cancer: Preventive Medication Carotid Artery Stenosis: … Obesity and Cardiovascular Health 1. … to promote a healthful diet and physical activity for cardiovascular disease prevention.
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

www.ahrq.gov (977)

psnet.ahrq.gov (864)

effectivehealthcare.ahrq.gov (685)

www.uspreventiveservicestaskforce.org (552)

hcup-us.ahrq.gov (442)

digital.ahrq.gov (340)

cds.ahrq.gov (60)

meps.ahrq.gov (30)

cdsic.ahrq.gov (13)

integrationacademy.ahrq.gov (12)

qualityindicators.ahrq.gov (3)

pso.ahrq.gov (2)

datatools.ahrq.gov (1)